Drug Profile
Research programme: proteasome inhibitors - 4SC/ViroLogik
Alternative Names: 4SC-206; SC 68896; VL 01Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator 4SC
- Developer 4SC; ViroLogik
- Class Small molecules
- Mechanism of Action Apoptosis stimulants; Proteasome inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Hepatitis C; HIV infections
- Discontinued Influenza A virus infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Germany (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Hepatitis-C in Germany
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-infections in Germany